Met Life Investment Management, LLC Forma Therapeutics Holdings, Inc. Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 May 10, 2024	BUY	$7.12 - $20.24 $33,022 - $93,873	4,638 Added 32.47%	18,921 $377,000
Q3 2022 Jun 14, 2023	BUY	$7.12 - $20.24 $134,717 - $382,961	18,921 New	18,921 $377,000
Q3 2022 Mar 22, 2023	BUY	$7.12 - $20.24 $33,022 - $93,873	4,638 Added 32.47%	18,921 $377,000
Q3 2022 Nov 14, 2022	BUY	$7.12 - $20.24 $33,022 - $93,873	4,638 Added 32.47%	18,921 $377,000
Q2 2022 May 10, 2024	SELL	$5.1 - $10.0 $23,699 - $46,470	-4,647 Reduced 24.55%	14,283 $98,000
Q2 2022 Jun 20, 2023	BUY	$5.1 - $10.0 $72,843 - $142,830	14,283 New	14,283 $98,000
Q2 2022 Mar 22, 2023	SELL	$5.1 - $10.0 $23,699 - $46,470	-4,647 Reduced 24.55%	14,283 $98,000
Q2 2022 Aug 11, 2022	SELL	$5.1 - $10.0 $23,699 - $46,470	-4,647 Reduced 24.55%	14,283 $98,000
Q1 2022 May 10, 2024	BUY	$8.34 - $14.69 $157,876 - $278,081	18,930 New	18,930 $176,000
Q1 2022 Jun 20, 2023	BUY	$8.34 - $14.69 $157,876 - $278,081	18,930 New	18,930 $176,000
Q1 2022 Mar 22, 2023	BUY	$8.34 - $14.69 $58,263 - $102,624	6,986 Added 58.49%	18,930 $176,000
Q1 2022 May 12, 2022	BUY	$8.34 - $14.69 $58,263 - $102,624	6,986 Added 58.49%	18,930 $176,000
Q4 2021 Jun 21, 2023	BUY	$13.6 - $24.89 $162,438 - $297,286	11,944 New	11,944 $169,000
Q3 2021 Jun 21, 2023	BUY	$21.22 - $25.7 $253,451 - $306,960	11,944 New	11,944 $276,000
Q2 2021 Jun 21, 2023	BUY	$22.86 - $30.95 $273,039 - $369,666	11,944 New	11,944 $297,000
Q1 2021 May 17, 2024	BUY	$24.58 - $42.82 $293,583 - $511,442	11,944 New	11,944 $334,000
Q1 2021 Jun 26, 2023	BUY	$24.58 - $42.82 $293,583 - $511,442	11,944 New	11,944 $335 Million
Q1 2021 Mar 22, 2023	BUY	$24.58 - $42.82 $120,687 - $210,246	4,910 Added 69.8%	11,944 $334,000
Q1 2021 May 14, 2021	BUY	$24.58 - $42.82 $120,687 - $210,246	4,910 Added 69.8%	11,944 $335,000
Q4 2020 Jun 22, 2023	BUY	$34.9 - $51.08 $245,486 - $359,296	7,034 New	7,034 $245,000
Q3 2020 May 24, 2024	BUY	$32.95 - $50.25 $231,770 - $353,458	7,034 New	7,034 $351 Million
Q3 2020 Jun 26, 2023	BUY	$32.95 - $50.25 $231,770 - $353,458	7,034 New	7,034 $350,000
Q3 2020 Mar 22, 2023	BUY	$32.95 - $50.25 $231,770 - $353,458	7,034 New	7,034 $350,000
Q3 2020 Nov 13, 2020	BUY	$32.95 - $50.25 $231,770 - $353,458	7,034 New	7,034 $351,000

Others Institutions Holding FMTX

# of Institutions

Shares Held

26.5K

Call Options Held

Put Options Held

View Full List

About Forma Therapeutics Holdings, Inc.

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

More about FMTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account